<DOC>
	<DOCNO>NCT02855281</DOCNO>
	<brief_summary>This prospective diagnostic pilot study create hypothesis regard immunocytochemistry ( ICC ) PD-L1 analysis pleural effusion NSCLC patient compare reference standard PD-L1 immunohistochemistry ( IHC ) . This comparison do assess sensitivity specificity PD-L1 detection ICC pleural effusion .</brief_summary>
	<brief_title>Sensitivity PDL-1-analysis From Pleural Effusion Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Presence malignant pleural effusion indication pleural puncture thoracoscopy Confirmed diagnosis nonsmall cell lung cancer accord ERS guideline Written inform consent Pregnancy and/or lactation Acute lifethreatening illness ( instable angina pectoris , acute pulmonary arterial embolism , myocardial infarction , etc . ) Any contraindication undergo thoracoscopy ( e.g . anticoagulation therapy discontinue procedure ) Any medical , psychological condition impair patient 's ability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>